{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T12:52:32Z","timestamp":1789908752161,"version":"4.0.1"},"reference-count":176,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"vor","delay-in-days":365,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1111\/1469-0691.12660","type":"journal-article","created":{"date-parts":[[2014,5,8]],"date-time":"2014-05-08T18:28:03Z","timestamp":1399573683000},"page":"27-48","source":"Crossref","is-referenced-by-count":178,"special_numbering":"S7","title":["Invasive fungal infections in solid organ transplant recipients"],"prefix":"10.1016","volume":"20","author":[{"given":"J.","family":"Gavald\u00e0","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Meije","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Fort\u00fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Roilides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Saliba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Lortholary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Grossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Cuenca-Estrella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/1469-0691.12660_bib1","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1086\/651262","article-title":"Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET)","volume":"50","author":"Pappas","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12660_bib2","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/01.tp.0000188953.86035.2d","article-title":"Bloodstream infections among heart transplant recipients","volume":"81","author":"Rodriguez","year":"2006","journal-title":"Transplantation"},{"key":"10.1111\/1469-0691.12660_bib3","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1111\/j.1600-6143.2007.01964.x","article-title":"Bloodstream infections among transplant recipients: results of a nationwide surveillance in Spain","volume":"7","author":"Moreno","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1111\/1469-0691.12660_bib4","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1086\/595688","article-title":"Evidence that graftsite candidiasis after kidney transplantation is acquired during organ recovery: a multicenter study in France","volume":"48","author":"Albano","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12660_bib5","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1590\/S0074-02762011000300014","article-title":"Epidemiology of fungal infections in liver transplant recipients: a six-year study of a large Brazilian liver transplantation centre","volume":"106","author":"Zicker","year":"2011","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"10.1111\/1469-0691.12660_bib6","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/1469-0691.12380","article-title":"Epidemiology and predictive factors for early and late mortality in Candida bloodstream infections: a population-based surveillance in Spain","volume":"20","author":"Puig-Asensio","year":"2014","journal-title":"Clin Microbiol Infect"},{"issue":"suppl 1","key":"10.1111\/1469-0691.12660_bib7","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1080\/13693780400020113","article-title":"Incidence of invasive aspergillosis following hematopoietic stem cell and solid organ transplantation: interim results of a prospective multicenter surveillance program","volume":"43","author":"Morgan","year":"2005","journal-title":"Med Mycol"},{"key":"10.1111\/1469-0691.12660_bib8","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1086\/345441","article-title":"Trends in risk profiles for and mortality associated with invasive aspergillosis among liver transplant recipients","volume":"36","author":"Singh","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12660_bib9","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1086\/430602","article-title":"Risk factors for invasive aspergillosis in solid-organ transplant recipients: a case-control study","volume":"41","author":"Gavalda","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12660_bib11","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.healun.2013.11.003","article-title":"Invasive aspergillosis among heart transplant recipients: a 24-year perspective","volume":"33","author":"Munoz","year":"2014","journal-title":"J Heart Lung Transplant"},{"key":"10.1111\/1469-0691.12660_bib12","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1053\/jlts.2002.36239","article-title":"Risk factors for invasive aspergillosis in liver transplant recipients","volume":"8","author":"Fortun","year":"2002","journal-title":"Liver Transpl"},{"key":"10.1111\/1469-0691.12660_bib15","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/S1053-2498(01)00364-3","article-title":"Nebulized amphotericin B prophylaxis for Aspergillus infection in lung transplantation: study of risk factors","volume":"20","author":"Monforte","year":"2001","journal-title":"J Heart Lung Transplant"},{"key":"10.1111\/1469-0691.12660_bib16","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/j.1600-6143.2004.00390.x","article-title":"Risk factors of invasive aspergillosis after heart transplantation: protective role of oral itraconazole prophylaxis","volume":"4","author":"Munoz","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1111\/1469-0691.12660_bib17","first-page":"112","article-title":"Prevalence and outcome of invasive fungal infections in 1,963 thoracic organ transplant recipients: a multicenter retrospective study. Italian Study Group of Fungal Infections in Thoracic Organ Transplant Recipients","volume":"70","author":"Grossi","year":"2000","journal-title":"Transplantation"},{"key":"10.1111\/1469-0691.12660_bib18","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1086\/598936","article-title":"Cryptococcosis in solid-organ, hematopoietic stem cell, and tissue transplant recipients: evidence-based evolving trends","volume":"48","author":"Sun","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12660_bib19","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1016\/j.transproceed.2012.09.059","article-title":"Risk factors, clinical characteristics, and outcomes of invasive fungal infections in solid organ transplant recipients","volume":"44","author":"Bodro","year":"2012","journal-title":"Transplant Proc"},{"key":"10.1111\/1469-0691.12660_bib20","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1086\/511438","article-title":"Cryptococcus neoformans in organ transplant recipients: impact of calcineurin-inhibitor agents on mortality","volume":"195","author":"Singh","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1111\/1469-0691.12660_bib21","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.3201\/eid1508.081384","article-title":"Spread of Cryptococcus gattii into Pacific Northwest region of the United States","volume":"15","author":"Datta","year":"2009","journal-title":"Emerg Infect Dis"},{"key":"10.1111\/1469-0691.12660_bib22","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.3201\/eid1810.120068","article-title":"Autochthonous and dormant Cryptococcus gattii infections in Europe","volume":"18","author":"Hagen","year":"2012","journal-title":"Emerg Infect Dis"},{"key":"10.1111\/1469-0691.12660_bib23","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1086\/649858","article-title":"Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of America","volume":"50","author":"Perfect","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12660_bib24","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3201\/eid0703.017302","article-title":"Cryptococcus neoformans infection in organ transplant recipients: variables influencing clinical characteristics and outcome","volume":"7","author":"Husain","year":"2001","journal-title":"Emerg Infect Dis"},{"issue":"suppl 5","key":"10.1111\/1469-0691.12660_bib25","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1469-0691.2009.02978.x","article-title":"Incidence of zygomycosis in transplant recipients","volume":"15","author":"Cuenca-Estrella","year":"2009","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/1469-0691.12660_bib26","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1399-3062.2010.00492.x","article-title":"Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients","volume":"12","author":"Neofytos","year":"2010","journal-title":"Transpl Infect Dis"},{"key":"10.1111\/1469-0691.12660_bib27","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1093\/cid\/cis195","article-title":"Mucormycosis in organ and stem cell transplant recipients","volume":"54","author":"Lanternier","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12660_bib28","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1086\/605445","article-title":"Zygomycosis in solid organ transplant recipients: a prospective, matched case-control study to assess risks for disease and outcome","volume":"200","author":"Singh","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1111\/1469-0691.12660_bib29","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1111\/j.1600-6143.2006.01496.x","article-title":"Zygomycosis in solid organ transplant recipients in a tertiary transplant center and review of the literature","volume":"6","author":"Almyroudis","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1111\/1469-0691.12660_bib30","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/TP.0b013e3181dde8fc","article-title":"Rhino-orbital-cerebral zygomycosis in solid organ transplant recipients","volume":"90","author":"Sun","year":"2010","journal-title":"Transplantation"},{"key":"10.1111\/1469-0691.12660_bib31","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/MCP.0b013e328326f410","article-title":"Fungal infections after lung transplantation","volume":"15","author":"Sole","year":"2009","journal-title":"Curr Opin Pulm Med"},{"issue":"suppl 7","key":"10.1111\/1469-0691.12660_bib32","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/1469-0691.12038","article-title":"ESCMID* guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures","volume":"18","author":"Cuenca-Estrella","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/1469-0691.12660_bib33","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1128\/JCM.44.1.143-150.2006","article-title":"Use of quantitative real-time PCR to study the kinetics of extracellular DNA released from Candida albicans, with implications for diagnosis of invasive candidiasis","volume":"44","author":"Kasai","year":"2006","journal-title":"J Clin Microbiol"},{"key":"10.1111\/1469-0691.12660_bib34","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1093\/cid\/cis200","article-title":"Performance of Candida real-time polymerase chain reaction, \u03b2-D-glucan assay, and blood cultures in the diagnosis of invasive candidiasis","volume":"54","author":"Nguyen","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12660_bib35","doi-asserted-by":"crossref","first-page":"4551","DOI":"10.1128\/JCM.41.10.4551-4558.2003","article-title":"Contribution of the Platelia Candida-specific antibody and antigen tests to early diagnosis of systemic Candida tropicalis infection in neutropenic adults","volume":"41","author":"Sendid","year":"2003","journal-title":"J Clin Microbiol"},{"key":"10.1111\/1469-0691.12660_bib36","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1093\/cid\/ciq206","article-title":"\u03b2-D-glucan assay for the diagnosis of invasive fungal infections: a meta-analysis","volume":"52","author":"Karageorgopoulos","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12660_bib37","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1086\/647942","article-title":"Diagnostic performance of the (1 \u2192 3)-\u03b2-D-glucan assay for invasive fungal disease","volume":"49","author":"Koo","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12660_bib38","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1128\/JCM.02473-12","article-title":"Comparison of (1 \u2192 3)-\u03b2-D-glucan, mannan\/anti-mannan antibodies, and Cand-Tec Candida antigen as serum biomarkers for candidemia","volume":"51","author":"Held","year":"2013","journal-title":"J Clin Microbiol"},{"key":"10.1111\/1469-0691.12660_bib39","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","volume":"46","author":"De Pauw","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12660_bib40","doi-asserted-by":"crossref","first-page":"4083","DOI":"10.1128\/JCM.01183-10","article-title":"The (1,3) \u03b2-D-glucan test as an aid to early diagnosis of invasive fungal infections following lung transplantation","volume":"48","author":"Alexander","year":"2010","journal-title":"J Clin Microbiol"},{"key":"10.1111\/1469-0691.12660_bib41","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1086\/432470","article-title":"Multicenter clinical evaluation of the (1 \u2192 3) \u03b2-D-glucan assay as an aid to diagnosis of fungal infections in humans","volume":"41","author":"Ostrosky-Zeichner","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12660_bib42","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1086\/588563","article-title":"Pseudomonas aeruginosa as a cause of 1,3-\u03b2-D-glucan assay reactivity","volume":"46","author":"Mennink-Kersten","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12660_bib43","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1007\/s00134-012-2616-y","article-title":"Value of \u03b2-D-glucan and Candida albicans germ tube antibody for discriminating between Candida colonization and invasive candidiasis in patients with severe abdominal conditions","volume":"38","author":"Leon","year":"2012","journal-title":"Intensive Care Med"},{"key":"10.1111\/1469-0691.12660_bib44","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1128\/JCM.01602-10","article-title":"PCR diagnosis of invasive candidiasis: systematic review and meta-analysis","volume":"49","author":"Avni","year":"2011","journal-title":"J Clin Microbiol"},{"key":"10.1111\/1469-0691.12660_bib45","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1128\/JCM.01650-09","article-title":"Comparison of whole blood, serum, and plasma for early detection of candidemia by multiplex-tandem PCR","volume":"48","author":"Lau","year":"2010","journal-title":"J Clin Microbiol"},{"key":"10.1111\/1469-0691.12660_bib46","unstructured":"Fortun J, Meije Y, Buitrago M et al. Clinical Validation of Multiplex Quantitative Real-Time PCR (RT-PCR) for Invasive Candidiasis (IC) in Patients (pts) Admitted in Intensive Care Unit (ICU). Preliminary analysis. 23rd European Congress of Clinical Microbiology and Infectious Diseases; 2013; April 27\u201330; Berlin. Abstract # P1050."},{"key":"10.1111\/1469-0691.12660_bib47","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0732-8893(98)00096-0","article-title":"Evaluation of CHROMagar Candida for presumptive identification of clinically important Candida species","volume":"32","author":"Powell","year":"1998","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1111\/1469-0691.12660_bib48","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1128\/JCM.43.6.2909-2912.2005","article-title":"Multicenter evaluation of a Candida albicans peptide nucleic acid fluorescent in situ hybridization probe for characterization of yeast isolates from blood cultures","volume":"43","author":"Wilson","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1111\/1469-0691.12660_bib49","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1128\/JCM.06148-11","article-title":"Evaluation of the yeast traffic light PNA FISH probes for identification of Candida species from positive blood cultures","volume":"50","author":"Hall","year":"2012","journal-title":"J Clin Microbiol"},{"key":"10.1111\/1469-0691.12660_bib50","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1128\/JCM.05742-11","article-title":"Direct maldi-tof mass spectrometry assay of blood culture broths for rapid identification of Candida species causing bloodstream infections: an observational study in two large microbiology laboratories","volume":"50","author":"Spanu","year":"2012","journal-title":"J Clin Microbiol"},{"key":"10.1111\/1469-0691.12660_bib51","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1097\/01.TP.0000044358.99414.B8","article-title":"The isolation of Aspergillus fumigatus from respiratory tract specimens in heart transplant recipients is highly predictive of invasive aspergillosis","volume":"75","author":"Munoz","year":"2003","journal-title":"Transplantation"},{"key":"10.1111\/1469-0691.12660_bib52","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.healun.2011.01.701","article-title":"A 2010 working formulation for the standardization of definitions of infections in cardiothoracic transplant recipients","volume":"30","author":"Husain","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"10.1111\/1469-0691.12660_bib53","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.crad.2007.12.009","article-title":"Radiological and clinical findings of pulmonary aspergillosis following solid organ transplant","volume":"63","author":"Park","year":"2008","journal-title":"Clin Radiol"},{"key":"10.1111\/1469-0691.12660_bib54","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S1053-2498(02)00477-1","article-title":"Aspergillus infections after lung transplantation: clinical differences in type of transplant and implications for management","volume":"22","author":"Singh","year":"2003","journal-title":"J Heart Lung Transplant"},{"issue":"suppl 1","key":"10.1111\/1469-0691.12660_bib55","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/jac\/dkq438","article-title":"Detection and investigation of invasive mould disease","volume":"66","author":"Cuenca-Estrella","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/1469-0691.12660_bib56","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/00007890-200101150-00023","article-title":"Aspergillus antigenemia sandwich-enzyme immunoassay test as a serodiagnostic method for invasive aspergillosis in liver transplant recipients","volume":"71","author":"Fortun","year":"2001","journal-title":"Transplantation"},{"key":"10.1111\/1469-0691.12660_bib57","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1086\/503427","article-title":"Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis","volume":"42","author":"Pfeiffer","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12660_bib58","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1128\/JCM.44.2.389-394.2006","article-title":"Occurrence and kinetics of false-positive Aspergillus galactomannan test results following treatment with \u03b2-lactam antibiotics in patients with hematological disorders","volume":"44","author":"Aubry","year":"2006","journal-title":"J Clin Microbiol"},{"key":"10.1111\/1469-0691.12660_bib59","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/TP.0b013e31819288d5","article-title":"False-positive results of Aspergillus galactomannan antigenemia in liver transplant recipients","volume":"87","author":"Fortun","year":"2009","journal-title":"Transplantation"},{"key":"10.1111\/1469-0691.12660_bib60","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1128\/JCM.42.1.435-438.2004","article-title":"Efficacy of galactomannan antigen in the Platelia Aspergillus enzyme immunoassay for diagnosis of invasive aspergillosis in liver transplant recipients","volume":"42","author":"Kwak","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1111\/1469-0691.12660_bib61","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1097\/01.tp.0000263992.41003.33","article-title":"Aspergillus galactomannan antigen in the bronchoalveolar lavage fluid for the diagnosis of invasive aspergillosis in lung transplant recipients","volume":"83","author":"Husain","year":"2007","journal-title":"Transplantation"},{"key":"10.1111\/1469-0691.12660_bib62","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1128\/JCM.00077-07","article-title":"Bronchoalveolar lavage galactomannan in diagnosis of invasive pulmonary aspergillosis among solid-organ transplant recipients","volume":"45","author":"Clancy","year":"2007","journal-title":"J Clin Microbiol"},{"key":"10.1111\/1469-0691.12660_bib63","doi-asserted-by":"crossref","first-page":"3842","DOI":"10.1128\/JCM.05316-11","article-title":"Evaluation of Aspergillus PCR protocols for testing serum specimens","volume":"49","author":"White","year":"2011","journal-title":"J Clin Microbiol"},{"key":"10.1111\/1469-0691.12660_bib64","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1399-3062.2008.00323.x","article-title":"Real-time PCR on the first galactomannan-positive serum sample for diagnosing invasive aspergillosis in liver transplant recipients","volume":"10","author":"Botterel","year":"2008","journal-title":"Transpl Infect Dis"},{"key":"10.1111\/1469-0691.12660_bib65","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1093\/cid\/cir185","article-title":"Comparison of an Aspergillus real-time polymerase chain reaction assay with galactomannan testing of bronchoalvelolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in lung transplant recipients","volume":"52","author":"Luong","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12660_bib66","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1034\/j.1399-3062.2002.t01-1-02005.x","article-title":"Cryptococcal meningitis: an analysis among 5,521 consecutive organ transplant recipients","volume":"4","author":"Wu","year":"2002","journal-title":"Transpl Infect Dis"},{"key":"10.1111\/1469-0691.12660_bib67","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1371\/journal.pmed.0040021","article-title":"Determinants of disease presentation and outcome during cryptococcosis: the CryptoA\/D study","volume":"4","author":"Dromer","year":"2007","journal-title":"PLoS Med"},{"key":"10.1111\/1469-0691.12660_bib68","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1097\/TP.0b013e3181814e76","article-title":"Central nervous system cryptococcosis in solid organ transplant recipients: clinical relevance of abnormal neuroimaging findings","volume":"86","author":"Singh","year":"2008","journal-title":"Transplantation"},{"key":"10.1111\/1469-0691.12660_bib69","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1086\/524738","article-title":"Pulmonary cryptococcosis in solid organ transplant recipients: clinical relevance of serum cryptococcal antigen","volume":"46","author":"Singh","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"suppl 4","key":"10.1111\/1469-0691.12660_bib70","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1600-6143.2009.02911.x","article-title":"Cryptococcosis in solid organ transplant recipients","volume":"9","author":"Singh","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1111\/1469-0691.12660_bib71","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1016\/j.transproceed.2011.06.020","article-title":"Italian guidelines for diagnosis, prevention, and treatment of invasive fungal infections in solid organ transplant recipients","volume":"43","author":"Grossi","year":"2011","journal-title":"Transplant Proc"},{"issue":"suppl 2","key":"10.1111\/1469-0691.12660_bib72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1469-0691.2011.03477.x","article-title":"Guidelines for the prevention of invasive mould diseases caused by filamentous fungi by the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC)","volume":"17","author":"Ruiz-Camps","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/1469-0691.12660_bib73","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1097\/01.tp.0000185622.91708.57","article-title":"Outcome, incidence, and timing of infectious complications in small bowel and multivisceral organ transplantation patients","volume":"80","author":"Guaraldi","year":"2005","journal-title":"Transplantation"},{"issue":"suppl 2","key":"10.1111\/1469-0691.12660_bib74","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0213-005X(12)70079-4","article-title":"Infection prevention in solid organ transplantation","volume":"30","author":"Gavalda","year":"2012","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1111\/1469-0691.12660_bib75","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0213-005X(12)70079-4","article-title":"Invasive fungal infection in solid organ transplant","volume":"30","author":"Gavalda","year":"2012","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1111\/1469-0691.12660_bib76","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1097\/00007890-200104150-00016","article-title":"Preemptive prophylaxis with a lipid preparation of amphotericin B for invasive fungal infections in liver transplant recipients requiring renal replacement therapy","volume":"71","author":"Singh","year":"2001","journal-title":"Transplantation"},{"key":"10.1111\/1469-0691.12660_bib77","doi-asserted-by":"crossref","first-page":"E454","DOI":"10.1111\/ctr.12129","article-title":"Fungal infections after liver transplantation: outcomes and risk factors revisited in the MELD era","volume":"27","author":"Saliba","year":"2013","journal-title":"Clin Transplant"},{"key":"10.1111\/1469-0691.12660_bib78","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.eimc.2011.01.008","article-title":"Guidelines for the treatment of invasive candidiasis and other yeasts. Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC). 2010 Update","volume":"29","author":"Aguado","year":"2011","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1111\/1469-0691.12660_bib79","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1053\/jlts.2000.7572","article-title":"Targeted prophylaxis with amphotericin B lipid complex in liver transplantation","volume":"6","author":"Singhal","year":"2000","journal-title":"Liver Transpl"},{"key":"10.1111\/1469-0691.12660_bib83","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1093\/jac\/dkg450","article-title":"Prevention of invasive fungal infections in liver transplant recipients: the role of prophylaxis with lipid formulations of amphotericin B in high-risk patients","volume":"52","author":"Fortun","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/1469-0691.12660_bib84","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1002\/lt.23410","article-title":"Safety of anidulafungin in solid organ transplant recipients","volume":"18","author":"Aguado","year":"2012","journal-title":"Liver Transpl"},{"key":"10.1111\/1469-0691.12660_bib85","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1097\/TP.0b013e3181932e76","article-title":"Prophylaxis with caspofungin for invasive fungal infections in high-risk liver transplant recipients","volume":"87","author":"Fortun","year":"2009","journal-title":"Transplantation"},{"key":"10.1111\/1469-0691.12660_bib86","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1097\/TP.0b013e31829d674f","article-title":"Micafungin versus amphotericin B lipid complex for the prevention of invasive fungal infections in high-risk liver transplant recipients","volume":"96","author":"Sun","year":"2013","journal-title":"Transplantation"},{"key":"10.1111\/1469-0691.12660_bib87","unstructured":"Saliba F, Fischer L, Pascher A et al. Micafungin as antifungal prophylaxis in high-risk liver transplantation: randomised multicentre trial. 16th Congress of the European Society for Organ Transplantation; 2013; September 8-11; Vienna. Abstract # P217."},{"key":"10.1111\/1469-0691.12660_bib88","unstructured":"Saliba F, Fischer L, Pascher A et al. Efficacy and safety of micafungin as antifungal prophylaxis in high-risk liver transplantation. 53rd International Congress on Antimicrobial Agents and Chemotherapy (ICAAC); 2013; September 10\u201313; Denver. Abstract # T810."},{"key":"10.1111\/1469-0691.12660_bib89","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1600-6143.2005.01176.x","article-title":"Invasive fungal infections in low-risk liver transplant recipients: a multi-center prospective observational study","volume":"6","author":"Pappas","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1111\/1469-0691.12660_bib90","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/TP.0b013e3182247bb4","article-title":"Universal prophylaxis with fluconazole for the prevention of early invasive fungal infection in low-risk liver transplant recipients","volume":"92","author":"San-Juan","year":"2011","journal-title":"Transplantation"},{"issue":"suppl 4","key":"10.1111\/1469-0691.12660_bib91","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1086\/421957","article-title":"Antifungal prophylaxis in solid-organ transplant recipients: considerations for clinical trial design","volume":"39","author":"Singh","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12660_bib92","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1002\/lt.20690","article-title":"Antifungal prophylaxis in liver transplant patients: a systematic review and meta-analysis","volume":"12","author":"Cruciani","year":"2006","journal-title":"Liver Transpl"},{"key":"10.1111\/1469-0691.12660_bib93","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1399-3062.2006.00156.x","article-title":"Variation in antifungal prophylaxis strategies in lung transplantation","volume":"8","author":"Husain","year":"2006","journal-title":"Transpl Infect Dis"},{"key":"10.1111\/1469-0691.12660_bib94","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/00007890-200108150-00036","article-title":"Safety of aerosolized amphotericin B lipid complex in lung transplant recipients","volume":"72","author":"Palmer","year":"2001","journal-title":"Transplantation"},{"key":"10.1111\/1469-0691.12660_bib97","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1128\/AAC.49.7.3028-3030.2005","article-title":"Efficacy of nebulized liposomal amphotericin B in treatment of experimental pulmonary aspergillosis","volume":"49","author":"Gavalda","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/1469-0691.12660_bib98","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.healun.2012.11.013","article-title":"Prophylaxis with nebulized liposomal amphotericin B for Aspergillus infection in lung transplant patients does not cause changes in the lipid content of pulmonary surfactant","volume":"32","author":"Monforte","year":"2013","journal-title":"J Heart Lung Transplant"},{"key":"10.1111\/1469-0691.12660_bib99","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1016\/j.transproceed.2008.09.020","article-title":"Efficiency and safety of inhaled amphotericin B lipid complex (Abelcet) in the prophylaxis of invasive fungal infections following lung transplantation","volume":"40","author":"Borro","year":"2008","journal-title":"Transplant Proc"},{"key":"10.1111\/1469-0691.12660_bib100","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.healun.2008.11.004","article-title":"Nebulized liposomal amphotericin B prophylaxis for Aspergillus infection in lung transplantation: pharmacokinetics and safety","volume":"28","author":"Monforte","year":"2009","journal-title":"J Heart Lung Transplant"},{"key":"10.1111\/1469-0691.12660_bib101","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1097\/01.TP.0000054233.60100.7A","article-title":"Nebulized amphotericin B concentration and distribution in the respiratory tract of lung-transplanted patients","volume":"75","author":"Monforte","year":"2003","journal-title":"Transplantation"},{"key":"10.1111\/1469-0691.12660_bib102","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1111\/j.1600-6143.2006.01548.x","article-title":"Voriconazole prophylaxis in lung transplant recipients","volume":"6","author":"Husain","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1111\/1469-0691.12660_bib103","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1111\/j.1600-6143.2012.04042.x","article-title":"Risk factors for voriconazole hepatotoxicity at 12 weeks in lung transplant recipients","volume":"12","author":"Luong","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1111\/1469-0691.12660_bib104","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1111\/j.1600-6143.2009.02734.x","article-title":"Antifungal prophylaxis with voriconazole or itraconazole in lung transplant recipients: hepatotoxicity and effectiveness","volume":"9","author":"Cadena","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1111\/1469-0691.12660_bib105","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.healun.2010.05.022","article-title":"Voriconazole exposure and geographic location are independent risk factors for squamous cell carcinoma of the skin among lung transplant recipients","volume":"29","author":"Vadnerkar","year":"2010","journal-title":"J Heart Lung Transplant"},{"key":"10.1111\/1469-0691.12660_bib106","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.healun.2012.02.033","article-title":"High cumulative dose exposure to voriconazole is associated with cutaneous squamous cell carcinoma in lung transplant recipients","volume":"31","author":"Singer","year":"2012","journal-title":"J Heart Lung Transplant"},{"key":"10.1111\/1469-0691.12660_bib107","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1111\/j.1524-4725.2012.02418.x","article-title":"Duration of voriconazole exposure: an independent risk factor for skin cancer after lung transplantation","volume":"38","author":"Zwald","year":"2012","journal-title":"Dermatol Surg"},{"key":"10.1111\/1469-0691.12660_bib108","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1093\/cid\/cit600","article-title":"A Multistep voriconazole-related phototoxic pathway may lead to skin carcinoma: results from a French Nationwide Study","volume":"57","author":"Epaulard","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"suppl 4","key":"10.1111\/1469-0691.12660_bib109","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1600-6143.2009.02909.x","article-title":"Candida in solid organ transplant recipients","volume":"9","author":"Pappas","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1111\/1469-0691.12660_bib110","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1086\/596757","article-title":"Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America","volume":"48","author":"Pappas","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12660_bib111","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1086\/520980","article-title":"Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis","volume":"45","author":"Pappas","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"suppl 7","key":"10.1111\/1469-0691.12660_bib112","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/1469-0691.12039","article-title":"ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients","volume":"18","author":"Cornely","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/1469-0691.12660_bib113","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1056\/NEJMoa021585","article-title":"Comparison of caspofungin and amphotericin B for invasive candidiasis","volume":"347","author":"Mora-Duarte","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1111\/1469-0691.12660_bib114","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/S0140-6736(07)60605-9","article-title":"Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial","volume":"369","author":"Kuse","year":"2007","journal-title":"Lancet"},{"key":"10.1111\/1469-0691.12660_bib115","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1086\/653935","article-title":"Early removal of central venous catheter in patients with candidemia does not improve outcome: analysis of 842 patients from 2 randomized clinical trials","volume":"51","author":"Nucci","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12660_bib116","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jinf.2008.12.008","article-title":"Candidemia in cancer patients: impact of early removal of non-tunneled central venous catheters on outcome","volume":"58","author":"Liu","year":"2009","journal-title":"J Infect"},{"key":"10.1111\/1469-0691.12660_bib117","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/MD.0b013e3182259d38","article-title":"The role of fluconazole in the treatment of Candida endocarditis: a meta-analysis","volume":"90","author":"Smego","year":"2011","journal-title":"Medicine (Baltimore)"},{"key":"10.1111\/1469-0691.12660_bib118","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1439-0507.2010.01884.x","article-title":"Fungal prosthetic valve endocarditis: Mayo Clinic experience with a clinicopathological analysis","volume":"54","author":"Boland","year":"2011","journal-title":"Mycoses"},{"issue":"suppl 1","key":"10.1111\/1469-0691.12660_bib119","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1080\/13693780400025237","article-title":"Aspergillosis in the CLEAR outcomes trial: working toward a real-world clinical perspective","volume":"43","author":"Kleinberg","year":"2005","journal-title":"Med Mycol"},{"key":"10.1111\/1469-0691.12660_bib120","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1086\/324620","article-title":"Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis","volume":"34","author":"Denning","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12660_bib121","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1056\/NEJMoa020191","article-title":"Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis","volume":"347","author":"Herbrecht","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1111\/1469-0691.12660_bib122","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1007\/s10096-003-0960-0","article-title":"Voriconazole in the treatment of invasive mold infections in transplant recipients","volume":"22","author":"Fortun","year":"2003","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1111\/1469-0691.12660_bib124","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1016\/j.transproceed.2007.05.012","article-title":"Voriconazole in the treatment of invasive aspergillosis in kidney transplant recipients","volume":"39","author":"Veroux","year":"2007","journal-title":"Transplant Proc"},{"key":"10.1111\/1469-0691.12660_bib125","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1182\/blood-2005-02-0733","article-title":"Improved outcome in central nervous system aspergillosis, using voriconazole treatment","volume":"106","author":"Schwartz","year":"2005","journal-title":"Blood"},{"key":"10.1111\/1469-0691.12660_bib126","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.healun.2007.10.002","article-title":"Caspofungin as first-line therapy for the treatment of invasive aspergillosis after thoracic organ transplantation","volume":"27","author":"Groetzner","year":"2008","journal-title":"J Heart Lung Transplant"},{"key":"10.1111\/1469-0691.12660_bib127","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/1471-2334-10-182","article-title":"Caspofungin use in daily clinical practice for treatment of invasive aspergillosis: results of a prospective observational registry","volume":"10","author":"Maertens","year":"2010","journal-title":"BMC Infect Dis"},{"key":"10.1111\/1469-0691.12660_bib128","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1399-3062.2009.00490.x","article-title":"Caspofungin for post solid organ transplant invasive fungal disease: results of a retrospective observational study","volume":"12","author":"Winkler","year":"2010","journal-title":"Transpl Infect Dis"},{"key":"10.1111\/1469-0691.12660_bib129","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/01.tp.0000202421.94822.f7","article-title":"Combination of voriconazole and caspofungin as primary therapy for invasive aspergillosis in solid organ transplant recipients: a prospective, multicenter, observational study","volume":"81","author":"Singh","year":"2006","journal-title":"Transplantation"},{"key":"10.1111\/1469-0691.12660_bib130","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1097\/TP.0b013e3181837585","article-title":"Posaconazole as salvage therapy in patients with invasive fungal infections after solid organ transplant","volume":"86","author":"Alexander","year":"2008","journal-title":"Transplantation"},{"key":"10.1111\/1469-0691.12660_bib132","first-page":"914","article-title":"Disseminated invasive aspergillosis successfully treated with micafungin in a renal transplant recipient","volume":"21","author":"Wadi","year":"2010","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"10.1111\/1469-0691.12660_bib133","first-page":"435","article-title":"Guidelines for the treatment of invasive fungal disease by Aspergillus spp. and other fungi issued by the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC). 2011 Update","volume":"29","author":"Fortun","year":"2011","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1111\/1469-0691.12660_bib134","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1086\/428734","article-title":"Voriconazole for invasive bone aspergillosis: a worldwide experience of 20 cases","volume":"40","author":"Mouas","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12660_bib135","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1086\/525258","article-title":"Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America","volume":"46","author":"Walsh","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12660_bib136","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.healun.2012.05.003","article-title":"Increased incidence of cutaneous squamous cell carcinoma in lung transplant recipients taking long-term voriconazole","volume":"31","author":"Feist","year":"2012","journal-title":"J Heart Lung Transplant"},{"key":"10.1111\/1469-0691.12660_bib137","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1097\/01.tp.0000173774.74388.49","article-title":"Antifungal management practices and evolution of infection in organ transplant recipients with cryptococcus neoformans infection","volume":"80","author":"Singh","year":"2005","journal-title":"Transplantation"},{"issue":"suppl 6","key":"10.1111\/1469-0691.12660_bib138","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1086\/429337","article-title":"Successful use of amphotericin B lipid complex in the treatment of cryptococcosis","volume":"40","author":"Baddour","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12660_bib139","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/S0149-2918(03)80125-X","article-title":"A systematic review of the antifungal effectiveness and tolerability of amphotericin B formulations","volume":"25","author":"Barrett","year":"2003","journal-title":"Clin Ther"},{"key":"10.1111\/1469-0691.12660_bib140","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1086\/647948","article-title":"Lipid formulations of amphotericin B significantly improve outcome in solid organ transplant recipients with central nervous system cryptococcosis","volume":"49","author":"Sun","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12660_bib141","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1016\/S0140-6736(04)16301-0","article-title":"Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial","volume":"363","author":"Brouwer","year":"2004","journal-title":"Lancet"},{"key":"10.1111\/1469-0691.12660_bib143","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1056\/NEJMoa1110404","article-title":"Combination antifungal therapy for cryptococcal meningitis","volume":"368","author":"Day","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1111\/1469-0691.12660_bib144","doi-asserted-by":"crossref","first-page":"e2870","DOI":"10.1371\/journal.pone.0002870","article-title":"Major role for amphotericin B-flucytosine combination in severe cryptococcosis","volume":"3","author":"Dromer","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1111\/1469-0691.12660_bib145","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1086\/430606","article-title":"An immune reconstitution syndrome-like illness associated with Cryptococcus neoformans infection in organ transplant recipients","volume":"40","author":"Singh","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12660_bib146","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1128\/AAC.35.4.726","article-title":"Combined therapy with fluconazole and flucytosine in murine cryptococcal meningitis","volume":"35","author":"Allendoerfer","year":"1991","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/1469-0691.12660_bib147","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1590\/S0036-46651994000600013","article-title":"Flucytosine + fluconazole association in the treatment of a murine experimental model of cryptococcosis","volume":"36","author":"Bava","year":"1994","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"10.1111\/1469-0691.12660_bib148","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/j.1875-9114.1990.tb02588.x","article-title":"Pharmacokinetics of fluconazole in serum and cerebrospinal fluid in a patient with AIDS and cryptococcal meningitis","volume":"10","author":"Chin","year":"1990","journal-title":"Pharmacotherapy"},{"key":"10.1111\/1469-0691.12660_bib149","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1086\/523576","article-title":"Reviews of anti-infective agents: posaconazole: a broad-spectrum triazole antifungal agent","volume":"45","author":"Nagappan","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12660_bib150","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1179\/joc.2009.21.1.108","article-title":"Voriconazole for cryptococcal meningitis in children with leukemia or receiving allogeneic hemopoietic stem cell transplant","volume":"21","author":"Bandettini","year":"2009","journal-title":"J Chemother"},{"key":"10.1111\/1469-0691.12660_bib151","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1097\/QAD.0b013e32832605fe","article-title":"Relationship of cerebrospinal fluid pressure, fungal burden and outcome in patients with cryptococcal meningitis undergoing serial lumbar punctures","volume":"23","author":"Bicanic","year":"2009","journal-title":"AIDS"},{"key":"10.1111\/1469-0691.12660_bib153","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1086\/313603","article-title":"Diagnosis and management of increased intracranial pressure in patients with AIDS and cryptococcal meningitis. The NIAID Mycoses Study Group and AIDS Cooperative Treatment Groups","volume":"30","author":"Graybill","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12660_bib154","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1097\/01.tp.0000180530.17683.02","article-title":"Allograft loss in renal transplant recipients with cryptococcus neoformans associated immune reconstitution syndrome","volume":"80","author":"Singh","year":"2005","journal-title":"Transplantation"},{"key":"10.1111\/1469-0691.12660_bib155","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1128\/AAC.44.3.739-746.2000","article-title":"Synergistic antifungal activities of bafilomycin A(1), fluconazole, and the pneumocandin MK-0991\/caspofungin acetate (L-743,873) with calcineurin inhibitors FK506 and L-685,818 against Cryptococcus neoformans","volume":"44","author":"Del Poeta","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/1469-0691.12660_bib156","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1086\/427213","article-title":"Cryptococcus neoformans meningitis at 2 hospitals in Washington, D.C.: adherence of health care providers to published practice guidelines for the management of cryptococcal disease","volume":"40","author":"Shoham","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12660_bib157","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1111\/j.1600-6143.2007.01994.x","article-title":"Cellulitis revealing a cryptococcosis-related immune reconstitution inflammatory syndrome in a renal allograft recipient","volume":"7","author":"Lanternier","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1111\/1469-0691.12660_bib158","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1128\/AAC.50.1.126-133.2006","article-title":"Posaconazole as salvage therapy for zygomycosis","volume":"50","author":"Greenberg","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/1469-0691.12660_bib159","doi-asserted-by":"crossref","first-page":"3968","DOI":"10.1128\/AAC.01065-06","article-title":"Deferasirox, an iron-chelating agent, as salvage therapy for rhinocerebral mucormycosis","volume":"50","author":"Reed","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/1469-0691.12660_bib160","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1086\/589857","article-title":"Combination polyene-caspofungin treatment of rhino-orbital-cerebral mucormycosis","volume":"47","author":"Reed","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12660_bib161","unstructured":"Lanternier F, Poiree S, Elie C et al. Pilot Prospective Study of High Dose (10 mg\/kg\/d) Liposomal Amphotericin B (L-AmB) for the Initial Treatment of Mucormycosis: AMBIZYGO Trial. 52nd International Congress on Antimicrobial Agents and Chemotherapy (ICAAC); 2012; September 9\u201312; San Francisco. Abstract # M1707."},{"key":"10.1111\/1469-0691.12660_bib162","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1128\/AAC.00969-06","article-title":"Posaconazole prophylaxis in experimental systemic zygomycosis","volume":"51","author":"Barchiesi","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/1469-0691.12660_bib163","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1128\/AAC.01577-10","article-title":"Combination therapy of murine mucormycosis or aspergillosis with iron chelation, polyenes, and echinocandins","volume":"55","author":"Ibrahim","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/1469-0691.12660_bib164","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1093\/jac\/dkr375","article-title":"The Deferasirox-Am-Bisome Therapy for Mucormycosis (DEFEAT Mucor) study: a randomized, double-blinded, placebo-controlled trial","volume":"67","author":"Spellberg","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/1469-0691.12660_bib165","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1128\/AAC.01388-07","article-title":"Treatment of scedosporiosis with voriconazole: clinical experience with 107 patients","volume":"52","author":"Troke","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/1469-0691.12660_bib166","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1080\/13693780802524506","article-title":"Epidemiology and outcome of Scedosporium prolificans infection, a review of 162 cases","volume":"47","author":"Rodriguez-Tudela","year":"2009","journal-title":"Med Mycol"},{"key":"10.1111\/1469-0691.12660_bib167","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s10096-002-0877-z","article-title":"Successful control of disseminated Scedosporium prolificans infection with a combination of voriconazole and terbinafine","volume":"22","author":"Howden","year":"2003","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1111\/1469-0691.12660_bib168","doi-asserted-by":"crossref","first-page":"4446","DOI":"10.1128\/AAC.00286-10","article-title":"International retrospective analysis of 73 cases of invasive fusariosis treated with voriconazole","volume":"54","author":"Lortholary","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/1469-0691.12660_bib170","article-title":"Improvement in the outcome of invasive fusariosis in the last decade","author":"Nucci","year":"2013","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/1469-0691.12660_bib171","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1592\/phco.26.12.1730","article-title":"Factors influencing the magnitude and clinical significance of drug interactions between azole antifungals and select immunosuppressants","volume":"26","author":"Saad","year":"2006","journal-title":"Pharmacotherapy"},{"key":"10.1111\/1469-0691.12660_bib172","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1016\/j.transproceed.2004.09.043","article-title":"Combined use of sirolimus and voriconazole in renal transplantation: a report of two cases","volume":"36","author":"Mathis","year":"2004","journal-title":"Transplant Proc"},{"key":"10.1111\/1469-0691.12660_bib173","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1592\/phco.27.6.825","article-title":"Effect of oral posaconazole on the pharmacokinetics of cyclosporine and tacrolimus","volume":"27","author":"Sansone-Parsons","year":"2007","journal-title":"Pharmacotherapy"},{"key":"10.1111\/1469-0691.12660_bib174","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1034\/j.1399-3062.2002.01004.x","article-title":"Safety and tolerability of caspofungin acetate in the treatment of fungal infections","volume":"4","author":"Sable","year":"2002","journal-title":"Transpl Infect Dis"},{"key":"10.1111\/1469-0691.12660_bib175","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1086\/501020","article-title":"Micafungin: a new echinocandin","volume":"42","author":"Chandrasekar","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12660_bib176","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1177\/0091270004270146","article-title":"Assessment of the safety and pharmacokinetics of anidulafungin when administered with cyclosporine","volume":"45","author":"Dowell","year":"2005","journal-title":"J Clin Pharmacol"},{"key":"10.1111\/1469-0691.12660_bib10","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1111\/j.1469-0691.2011.03548.x","article-title":"Epidemiological trends in invasive aspergillosis in France: the SAIF network (2005\u20132007)","volume":"17","author":"Lortholary","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/1469-0691.12660_bib13","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.idc.2010.01.005","article-title":"Infection in organ transplantation: risk factors and evolving patterns of infection","volume":"24","author":"Fishman","year":"2010","journal-title":"Infect Dis Clin North Am"},{"key":"10.1111\/1469-0691.12660_bib14","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.eimc.2011.12.005","article-title":"Aspergillosis. Clinical forms and treatment","volume":"30","author":"Fortun","year":"2012","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1111\/1469-0691.12660_bib80","doi-asserted-by":"crossref","first-page":"3965","DOI":"10.1016\/j.transproceed.2005.10.043","article-title":"Prospective interventional study to evaluate the efficacy and safety of liposomal amphotericin B as prophylaxis of fungal infections in high-risk liver transplant recipients","volume":"37","author":"Castroagudin","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1111\/1469-0691.12660_bib81","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1002\/lt.21331","article-title":"Effect of prophylaxis on fungal infection and costs for high-risk liver transplant recipients","volume":"13","author":"Reed","year":"2007","journal-title":"Liver Transpl"},{"key":"10.1111\/1469-0691.12660_bib82","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1399-3062.2008.00361.x","article-title":"Outcomes of antifungal prophylaxis in high-risk liver transplant recipients","volume":"11","author":"Hadley","year":"2009","journal-title":"Transpl Infect Dis"},{"key":"10.1111\/1469-0691.12660_bib95","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/01.TP.0000101516.08327.A9","article-title":"Comparative safety of amphotericin B lipid complex and amphotericin B deoxycholate as aerosolized antifungal prophylaxis in lung-transplant recipients","volume":"77","author":"Drew","year":"2004","journal-title":"Transplantation"},{"key":"10.1111\/1469-0691.12660_bib96","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.healun.2009.11.603","article-title":"Feasibility, tolerability, and outcomes of nebulized liposomal amphotericin B for Aspergillus infection prevention in lung transplantation","volume":"29","author":"Monforte","year":"2010","journal-title":"J Heart Lung Transplant"},{"key":"10.1111\/1469-0691.12660_bib123","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.healun.2003.10.014","article-title":"Superiority of voriconazole over amphotericin B in the treatment of invasive aspergillosis after heart transplantation","volume":"24","author":"Wieland","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"10.1111\/1469-0691.12660_bib131","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.jinf.2006.03.003","article-title":"Micafungin (FK463), alone or in combination with other systemic antifungal agents, for the treatment of acute invasive aspergillosis","volume":"53","author":"Denning","year":"2006","journal-title":"J Infect"},{"key":"10.1111\/1469-0691.12660_bib142","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1056\/NEJM199707033370103","article-title":"Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group","volume":"337","author":"van der Horst","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1111\/1469-0691.12660_bib152","doi-asserted-by":"crossref","first-page":"E64","DOI":"10.1086\/340525","article-title":"Use of ventriculo-peritoneal shunts to treat uncontrollable intracranial hypertension in patients who have cryptococcal meningitis without hydrocephalus","volume":"34","author":"Liliang","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12660_bib169","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1128\/CMR.00014-07","article-title":"Fusarium infections in immunocompromised patients","volume":"20","author":"Nucci","year":"2007","journal-title":"Clin Microbiol Rev"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14605000?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14605000?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,26]],"date-time":"2024-05-26T14:12:48Z","timestamp":1716732768000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X14605000"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":176,"alternative-id":["S1198743X14605000"],"URL":"https:\/\/doi.org\/10.1111\/1469-0691.12660","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]}}}